Pharma Ventures Pty Ltd Mayne serves as Executive at HedgePath Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Pharma Ventures Pty Ltd Mayne has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 15, 2018 involved transacting 184,798 shares valued at $0.
Pharma Ventures Pty Ltd Mayne currently holds 0 shares of HedgePath Pharmaceuticals, Inc. (HPPI*), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pharma Ventures Pty Ltd Mayne has been a net neutral trader of HPPI* stock. They have purchased $0 and sold $0 worth of shares.
Pharma Ventures Pty Ltd Mayne's most recent insider trade was on Jul 15, 2018, when they sold 184,798 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |